Clarus Therapeutics Holdings Inc (CRXT) has fallen Monday morning, with the stock falling -25.00% in pre-market trading to 1.35. CRXT's short-term technical score of 67 indicates that the stock has traded more bullishly over the last month than 67% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 18 out of 146 industries, Clarus Therapeutics Holdings Inc ranks higher than 45% of stocks. Clarus Therapeutics Holdings Inc has risen 9.09% over the past month, closing at $1.89 on March 28. During this period of time, the stock fell as low as $0.85 and as high as $3.94. CRXT has an average analyst recommendation of Strong Buy. The company has an average price target of $7.20.
News Home
Clarus Therapeutics Holdings Inc has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Drug Manufacturers - General industry which is number 18 by this metric, CRXT ranks better than 21% of stocks.
Clarus Therapeutics Holdings Inc (CRXT) is down 25.00% Monday In Premarket Trading
Mentioned in this article
CRXT has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on CRXT!